Diagnosis and Staging of Hepatocellular Carcinoma

AUTHORS

Amir H Davarpanah 1 , *

1 Division of Abdominal and Cardiothoracic Imaging, Massachusetts General Hospital, Boston

How to Cite: Davarpanah A H. Diagnosis and Staging of Hepatocellular Carcinoma, Iran J Radiol. Online ahead of Print ; 14(Special Issue):e48398. doi: 10.5812/iranjradiol.48398.

ARTICLE INFORMATION

Iranian Journal of Radiology: 14 (Special Issue); e48398
Published Online: April 12, 2017
Article Type: Abstract
Received: December 20, 2016
Accepted: February 7, 2017
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common tumor in the world, and its incidence is increasing. It is second most common cause of cancer related death worldwide and fastest growing cause of cancer death in the United States. Cirrhosis is the most important clinical risk factor for HCC, with approximately 80% of cases of HCC developing in patients with a cirrhotic liver. HCC differs from most malignancies because it is commonly diagnosed on the basis of imaging features alone, without histologic confirmation. The prognosis of HCC depends largely on the stage at which the tumor is detected. The detection of HCC early in its development, therefore, is critical to improve the survival of affected patients. In this talk, we discuss surveillance strategies with ultrasonography (US) as the primary screening imaging test as well as current state of the art for the imaging-based diagnosis and staging of HCC.

Full Text

Full text is available in PDF

© 2017, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
COMMENTS

LEAVE A COMMENT HERE: